All Stories

  1. Selecting appropriate weight loss pharmacotherapies in older adults to reduce cardiovascular risk

    Article • Expert Opinion on Pharmacotherapy, August 2018, Taylor & Francis

    Salvatore Carbone, Dr Dave L Dixon

  2. A Trial of Blood-Pressure Reduction in Black Barbershops

    Article • New England Journal of Medicine, July 2018, New England Journal of Medicine (NEJM/MMS)

    Dr Dave L Dixon

  3. The 2017 American College of Cardiology/American Heart Association hypertension guideline and opportunities for community pharmacists

    Article • Journal of the American Pharmacists Association, July 2018, Elsevier

    Dr Dave L Dixon

  4. Response to Comment on Buckley et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738

    Article • Diabetes Care, May 2018, American Diabetes Association

    Dr Dave L Dixon

  5. Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: a Systematic Review

    Article • Current Atherosclerosis Reports, May 2018, Springer Science + Business Media

    Dr Dave L Dixon

  6. Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics

    Article • Diabetes Obesity and Metabolism, April 2018, Wiley

    Leo Buckley, Dr Dave L Dixon

  7. A Prescription for Prescribing: Ensuring Continued Pharmacist Preparedness

    Article • Annals of Pharmacotherapy, March 2018, SAGE Publications

    Dr Dave L Dixon

  8. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants

    Article • Diabetes Obesity and Metabolism, March 2018, Wiley

    Dr Dave L Dixon

  9. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline

    Article • Journal of Clinical Lipidology, March 2018, Elsevier

    Dr Dave L Dixon

  10. Evolving Role of Non-Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, January 2018, Wiley

    Dr Dave L Dixon, Michael S. Kelly

  11. Treatment of Hypertension to Prevent and Treat Heart Failure in Diabetic Patients Should Include Sodium Glucose Co-Transporter 2 Inhibitors

    Article • JACC Heart Failure, January 2018, Elsevier

    Dr Dave L Dixon

  12. Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review

    Article • Pharmacy Practice, December 2017, Centro de Investigaciones y Publicaciones Farmaceuticas (CIPF)

    Dr Dave L Dixon

  13. Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population

    Article • Journal of Clinical Hypertension, December 2017, Wiley

    Dr Dave L Dixon

  14. Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure

    Article • Circulation Heart Failure, November 2017, Wolters Kluwer Health

    Prof. Giuseppe Biondi-Zoccai, Dr Dave L Dixon

  15. Pharmacists as Integral Members of the Cardiovascular Team

    Article • JAMA Cardiology, November 2017, American Medical Association (AMA)

    Dr Dave L Dixon

  16. Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions

    Article • Current Atherosclerosis Reports, October 2017, Springer Science + Business Media

    Dr Dave L Dixon

  17. Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction

    Article • JACC Basic to Translational Science, October 2017, Elsevier

    Dr Dave L Dixon

  18. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP

    Article • Diabetes Care, September 2017, American Diabetes Association

    Dr Dave L Dixon

  19. Medication Reconciliation vs Medication Review

    Article • JAMA, September 2017, American Medical Association (AMA)

    Dr Dave L Dixon

  20. Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up

    Article • Drug Design Development and Therapy, July 2017, Dove Medical Press

    Dr Dave L Dixon

  21. Pharmacologic approaches for the management of patients with moderately elevated triglycerides (150–499 mg/dL)

    Article • Journal of Clinical Lipidology, July 2017, Elsevier

    Dr Dave L Dixon, Michael S. Kelly

  22. Interleukin‐1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D‐ HART2 )

    Article • Clinical Cardiology, May 2017, Wiley

    Leo Buckley, Prof. Giuseppe Biondi-Zoccai, Dr Dave L Dixon

  23. Effects of Sodium‐Glucose Cotransporter 2 Inhibitors on 24‐Hour Ambulatory Blood Pressure: A Systematic Review and Meta‐Analysis

    Article • Journal of the American Heart Association, May 2017, Wolters Kluwer Health

    Roy Brown, Dr Dave L Dixon, Michael S. Kelly

  24. Practice Patterns for Addressing LDL-Cholesterol Levels Below 40 in Patients Receiving Statin Therapy

    Article • Journal of Clinical Lipidology, May 2017, Elsevier

    Dr Dave L Dixon

  25. Best Practice for Switching Stable Warfarin Patients

    Article • January 2017, Springer Science + Business Media

    Dr Dave L Dixon

  26. Significance of P-glycoprotein (P-gp) Drug-Drug Interactions

    Article • January 2017, Springer Science + Business Media

    Dr Dave L Dixon

  27. Obesity Contributes to Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

    Article • Journal of the American College of Cardiology, December 2016, Elsevier

    Dr Dave L Dixon

  28. Letter by Dixon et al Regarding Article, “Watching Television and Risk of Mortality From Pulmonary Embolism Among Japanese Men and Women: The JACC Study (Japan Collaborative Cohort)”

    Article • Circulation, November 2016, Wolters Kluwer Health

    Dr Dave L Dixon

  29. A review of PCSK9 inhibition and its effects beyond LDL receptors

    Article • Journal of Clinical Lipidology, September 2016, Elsevier

    Dr Dave L Dixon

  30. Effectiveness of a Pharmacist-Physician Team-Based Collaboration to Improve Long-Term Blood Pressure Control at an Inner-City Safety-Net Clinic

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2016, Wiley

    Dr Dave L Dixon

  31. Effectiveness of Pharmacist-Led Amiodarone Monitoring Services on Improving Adherence to Amiodarone Monitoring Recommendations: A Systematic Review

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, February 2016, Wiley

    Dr Dave L Dixon, Roy Brown, Michael S. Kelly

  32. Interleukin-1 Blockade In Acute Decompensated Heart Failure

    Article • Journal of Cardiovascular Pharmacology, February 2016, Wolters Kluwer Health

    Dr Dave L Dixon, Prof. Giuseppe Biondi-Zoccai

  33. Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure

    Article • The American Journal of Cardiology, January 2016, Elsevier

    Dr Dave L Dixon

  34. New metabolic syndrome care model

    Article • Journal of the American College of Cardiology, September 2015, Elsevier

    Dr Dave L Dixon

  35. Potassium levels in acute myocardial infarction: definitely worth paying attention to

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, June 2015, Oxford University Press (OUP)

    Dr Dave L Dixon

  36. Critical appraisal of dabigatran in the treatment of deep vein thrombosis and pulmonary embolism

    Article • Journal of Blood Medicine, June 2015, Dove Medical Press

    Dr Dave L Dixon

  37. Collaborative Drug Therapy Management and Comprehensive Medication Management―2015

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2015, Wiley

    Dr Dave L Dixon

  38. Current Drug Treatment of Hyperlipidemia in Older Adults

    Article • Drugs & Aging, January 2015, Springer Science + Business Media

    Dr Dave L Dixon

  39. Interprofessional Education Team-Based Learning Series: Obesity Module

    Article • MedEdPORTAL, January 2015, Association of American Medical Colleges

    Dr Dave L Dixon

  40. Pharmacologic and Surgical Interventions to Improve Functional Capacity in Heart Failure

    Article • Heart Failure Clinics, January 2015, Elsevier

    Dr Dave L Dixon, Prof. Giuseppe Biondi-Zoccai

  41. Considerations for Dofetilide Use in the Elderly

    Article • The Consultant Pharmacist, April 2014, American Society of Consultant Pharmacists

    Dr Dave L Dixon

  42. Lomitapide and Mipomersen

    Article • The Journal of Cardiovascular Nursing, January 2014, Wolters Kluwer Health

    Dr Dave L Dixon

  43. Interprofessional Team-Based Learning Module: Anticoagulation

    Article • MedEdPORTAL, January 2013, Association of American Medical Colleges

    Dr Dave L Dixon

  44. Short-term outcomes of an employer-sponsored diabetes management program at an ambulatory care pharmacy clinic

    Article • American Journal of Health-System Pharmacy, December 2011, American Society of Health System Pharmacists

    Dr Dave L Dixon

  45. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing

    Article • Journal of Clinical Lipidology, March 2010, Elsevier

    Dr Dave L Dixon

  46. Interaction Between Gemfibrozil and Warfarin: Case Report and Review of the Literature

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, June 2009, Wiley

    Dr Dave L Dixon

  47. Safety of Enoxaparin Bridge Therapy in Patients with Mechanical Heart Valves

    Article • Annals of Pharmacotherapy, January 2008, SAGE Publications

    Dr Dave L Dixon